With vaccine sales on the decline, these are tough times for Merck to launch its new pneumococcal shot Capvaxive. | With ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 1 study titled ‘A Study to Learn About ...

A series of recommended shots that health providers administer to children as they age has been a recent target of President ...

While the company’s sales outlook was otherwise rosy, Merck took sales hits on Gardisil, Proquad, Varivax and Vaxneuvance.

Pneumococcal disease poses a severe risk to Indian adults, particularly those with chronic health issues. Despite effective ...

Several observational analyses suggest higher cardiovascular and dementia risks in those with and without HIV who get ...

Eligibility for this vaccination is suddenly a timely question. A senior health editor reports on her real-time experience.

Infectious disease researchers found the vaccine, used to prevent herpes zoster, or shingles, is also linked to lower risks ...

Merck & Co. Inc. (NYSE:MRK) on Thursday released results from the Phase 3 STRIDE-13 trial evaluating Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) at the European Society of Clinical ...

The shingles vaccine may cut dementia risk by up to 33%, per new research. Here, experts explain how it works and what it may mean for brain health.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive results from the Phase 3 STRIDE-13 trial evaluating CAPVAXIVE® (Pneumococcal 21-valent Conjugate ...

RESIDENTS are being urged to take up the flu and Covid-19 vaccine as the winter weather sets in. The council says getting ...